TEL AVIV, ISRAEL — Most Israeli pain specialists with an opinion on the issue believe that cannabis is a safe and effective analgesic agent, according to survey data published in the Journal of Pain Research. Investigators surveyed the opinions of over half of all practicing pain clinicians in Israel. The Israeli government has regulated the […]
BIRMINGHAM, AL — Epilepsy patients administered the standardized CBD extract Epidiolex experience a significant reduction in seizures over an extended period of time, according to clinical trial data published in the journal Epilepsy & Behavior. Investigators at the University of Alabama at Birmingham assessed the long-term daily administration of Epidiolex in a cohort of 132 […]
BOCHUM, GERMANY — Cannabinoid treatment is associated with improvements in dystonia in patients with early-onset Huntington’s disease, according to observational data published online ahead of print in the Journal of Huntington’s Disease. A team of investigators from Germany and Austria assessed the treatment of various synthetic or organic cannabinoid preparations – including Sativex, dronabinol, and nabilone – in seven HD patients who […]
The daily administration of CBD (cannabidiol) as an adjunctive therapy mitigates psychotic symptoms in patients with schizophrenia, according to clinical trial data published online ahead of print in The American Journal of Psychiatry. British researchers assessed the adjunctive use of CBD compared to placebo over a six-week period in a randomized trial of 88 schizophrenic patients. Participants ingested 1000mg of […]
LONDON, UK — The daily administration of CBD (cannabidiol) as an adjunctive therapy mitigates psychotic symptoms in patients with schizophrenia, according to clinical trial data published online ahead of print in The American Journal of Psychiatry. British researchers assessed the adjunctive use of CBD compared to placebo over a six-week period in a randomized trial of 88 schizophrenic patients. Participants ingested […]
Denver, CO (PRWEB) April 21, 2015
On the eve of 4/20, the celebrated marijuana holiday Cannabis Patient Network Institute, Co-Founder Regina Nelson made a big announcement. Now, CEO of The eCS Therapy Center an approved 501(c)(3) organization, Nelson states, “The eCS Therapy Center is an organization focused on cannabis education for the masses and providing cannabis patient services like peer-counseling and therapy planning.” The eCS Therapy Center will go beyond services currently offered by dispensaries because I.R.S. regulations prevent even patient-centered owners from deducting salaries and other normal expenses associated with the sale of cannabis. Nelson hopes The eCS Therapy Center and the network of peer-counselors she’s already begun training will fill this void. She says she is looking forward to hosting cannabis therapy centers across the nation.
The eCS Therapy Center will open its first office in Colorado Springs, CO late in the summer and a second office in Peoria, IL before the end of the year. As well, a national toll-free hotline is expected to be fully operational this summer. Nelson has her hands full with the launch of this new organization and Cannabis Patient Network Institute (CPNI) the non-profit she and Mark Pedersen co-founded in 2013. Pedersen is also the author of the “Missouri Cannabis Restoration and Protection Act” now petitioning for the 2016 ballot.
In 2014 CPNI managed to provide more than $ 70,000 in educational services, patient counseling, and cannabis oil on a budget of only $ 20,000—most of which Nelson and Pedersen funded personally. Nelson is hoping that the launch of The eCS Therapy Center and CPNI’s Affiliation with it will help CPNI grow into a larger benevolence ministry. “Our sponsors understand the need is great.”
Nelson plans to release the “My eCS Therapy Journal” in June—calling the book a resource text for patients desiring more information on the use of cannabis as medicine. Her book, “Theorist-at-Large: One Woman’s Ambiguous Journey into Medical Cannabis” is now available on Amazon.